Journey Medical Corporation (DERM) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Journey Medical Corporation, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -16.52x | -5.44x | -27.26x | -1.14x | -2.12x | 29.96x |
| P/B Ratio | 5.93x | 3.98x | 5.16x | 1.98x | 2.22x | 15.38x |
| P/S Ratio | 3.05x | 1.42x | 1.33x | 0.46x | 1.48x | 3.55x |
| Profitability | ||||||
| Gross Margin | 59.3% | 62.8% | 66.3% | 58.2% | 49.2% | 67.2% |
| Operating Margin | -13.2% | -24.4% | -2.6% | -37.4% | -55.2% | 17.6% |
| Net Margin | -18.5% | -26.1% | -4.9% | -40.2% | -69.7% | 11.9% |
| EBITDA Margin | -6.2% | -15.0% | 2.4% | -31.5% | -51.9% | 20.8% |
| Liquidity | ||||||
| Current Ratio | 1.79x | 1.37x | 1.35x | 1.16x | 1.64x | 1.26x |
| Quick Ratio | 1.53x | 0.96x | 1.10x | 0.95x | 1.45x | 1.21x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 1.28x | 0.87x | 1.35x | 0.02x | 0.96x |
YoY = year-over-year change. Source: FMP..